National Status: Improving
Most Recent Data:
2.25
deaths with hepatitis C as the underlying or contributing cause per 100,000 population
(2024) *
National Target:
1.44
per 100,000 1
*
Desired Direction:
Decrease desired
National Baseline:
4.13 deaths with hepatitis C as the underlying or contributing cause per 100,000 population were reported in 2017 *
* Age adjusted to the year 2000 standard population.
View CI in the chart by hovering over a data point.
View SE in the chart by hovering over a data point.
Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available
Deaths with hepatitis C as the underlying or contributing cause, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Total |
4.13 CI 4.07 / 4.20 SE 0.032 |
3.72 CI 3.66 / 3.78 SE 0.030 |
3.33 CI 3.28 / 3.39 SE 0.029 |
3.45 CI 3.39 / 3.50 SE 0.029 |
3.18 CI 3.13 / 3.24 SE 0.028 |
2.87 CI 2.82 / 2.92 SE 0.026 |
2.49 CI 2.44 / 2.54 SE 0.024 |
2.25 CI 2.21 / 2.30 SE 0.023 |
Deaths with hepatitis C as the underlying or contributing cause by Sex, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Male |
6.12 CI 6.01 / 6.23 SE 0.056 |
5.53 CI 5.42 / 5.63 SE 0.053 |
4.96 CI 4.86 / 5.06 SE 0.050 |
5.07 CI 4.97 / 5.17 SE 0.050 |
4.61 CI 4.52 / 4.70 SE 0.048 |
4.18 CI 4.10 / 4.27 SE 0.045 |
3.65 CI 3.57 / 3.74 SE 0.042 |
3.26 CI 3.19 / 3.34 SE 0.039 |
Female |
2.32 CI 2.26 / 2.39 SE 0.034 |
2.09 CI 2.02 / 2.15 SE 0.032 |
1.83 CI 1.77 / 1.89 SE 0.030 |
1.94 CI 1.88 / 2.00 SE 0.031 |
1.85 CI 1.79 / 1.91 SE 0.030 |
1.67 CI 1.61 / 1.72 SE 0.028 |
1.43 CI 1.38 / 1.49 SE 0.026 |
1.33 CI 1.28 / 1.38 SE 0.025 |
Deaths with hepatitis C as the underlying or contributing cause by Race/Ethnicity, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
American Indian or Alaska Native only |
DNA |
6.65 CI 5.86 / 7.55 SE 0.418 |
6.17 CI 5.43 / 7.01 SE 0.392 |
7.31 CI 6.50 / 8.21 SE 0.425 |
7.16 CI 6.37 / 8.03 SE 0.412 |
6.17 CI 5.45 / 6.98 SE 0.380 |
5.22 CI 4.55 / 5.96 SE 0.349 |
3.92 CI 3.37 / 4.55 SE 0.292 |
Asian only |
DNA |
1.38 CI 1.22 / 1.56 SE 0.085 |
1.37 CI 1.21 / 1.55 SE 0.084 |
1.39 CI 1.24 / 1.57 SE 0.082 |
1.29 CI 1.14 / 1.45 SE 0.078 |
0.99 CI 0.86 / 1.13 SE 0.066 |
1.02 CI 0.90 / 1.16 SE 0.067 |
0.85 CI 0.74 / 0.98 SE 0.059 |
Native Hawaiian or Other Pacific Islander only |
DNA |
3.41 CI 2.16 / 5.29 SE 0.710 |
2.89 CI 1.74 / 4.66 SE 0.665 |
1.55 CI 0.82 / 2.85 SE 0.434 |
2.78 CI 1.73 / 4.38 SE 0.601 |
2.30 CI 1.40 / 3.69 SE 0.517 |
1.84 CI 1.05 / 3.12 SE 0.462 |
DSU |
Black or African American only |
DNA |
6.19 CI 5.97 / 6.43 SE 0.116 |
5.37 CI 5.17 / 5.59 SE 0.106 |
5.58 CI 5.37 / 5.80 SE 0.108 |
4.87 CI 4.68 / 5.07 SE 0.100 |
4.55 CI 4.36 / 4.74 SE 0.096 |
3.83 CI 3.66 / 4.01 SE 0.087 |
3.46 CI 3.30 / 3.63 SE 0.082 |
White only |
DNA |
3.55 CI 3.48 / 3.61 SE 0.033 |
3.17 CI 3.11 / 3.24 SE 0.031 |
3.29 CI 3.23 / 3.36 SE 0.032 |
3.07 CI 3.01 / 3.13 SE 0.031 |
2.79 CI 2.73 / 2.84 SE 0.029 |
2.42 CI 2.37 / 2.47 SE 0.027 |
2.22 CI 2.17 / 2.27 SE 0.026 |
2 or more races |
DNA |
2.95 CI 2.49 / 3.50 SE 0.247 |
2.89 CI 2.44 / 3.42 SE 0.242 |
2.66 CI 2.23 / 3.15 SE 0.225 |
2.77 CI 2.35 / 3.26 SE 0.223 |
2.50 CI 2.10 / 2.96 SE 0.211 |
1.86 CI 1.52 / 2.26 SE 0.180 |
1.57 CI 1.27 / 1.93 SE 0.163 |
Hispanic or Latino |
DNA |
4.64 CI 4.45 / 4.85 SE 0.102 |
3.84 CI 3.66 / 4.02 SE 0.091 |
4.00 CI 3.82 / 4.19 SE 0.092 |
3.67 CI 3.50 / 3.85 SE 0.087 |
3.04 CI 2.88 / 3.19 SE 0.078 |
2.49 CI 2.36 / 2.63 SE 0.069 |
2.15 CI 2.03 / 2.27 SE 0.062 |
Not Hispanic or Latino |
DNA |
3.58 CI 3.52 / 3.64 SE 0.032 |
3.25 CI 3.19 / 3.31 SE 0.030 |
3.35 CI 3.29 / 3.41 SE 0.031 |
3.12 CI 3.06 / 3.17 SE 0.030 |
2.85 CI 2.80 / 2.91 SE 0.028 |
2.50 CI 2.45 / 2.55 SE 0.026 |
2.28 CI 2.23 / 2.33 SE 0.025 |
American Indian or Alaska Native only, not Hispanic or Latino |
DNA |
9.21 CI 8.05 / 10.51 SE 0.612 |
8.55 CI 7.46 / 9.78 SE 0.576 |
10.64 CI 9.41 / 12.00 SE 0.647 |
9.99 CI 8.82 / 11.29 SE 0.615 |
9.16 CI 8.02 / 10.43 SE 0.600 |
7.62 CI 6.59 / 8.79 SE 0.545 |
5.91 CI 5.03 / 6.93 SE 0.468 |
Asian only, not Hispanic or Latino |
DNA |
1.35 CI 1.18 / 1.53 SE 0.085 |
1.35 CI 1.19 / 1.53 SE 0.084 |
1.40 CI 1.25 / 1.58 SE 0.083 |
1.27 CI 1.12 / 1.44 SE 0.078 |
0.98 CI 0.86 / 1.13 SE 0.067 |
0.97 CI 0.85 / 1.11 SE 0.065 |
0.83 CI 0.72 / 0.95 SE 0.059 |
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino |
DNA |
3.49 CI 2.11 / 5.63 SE 0.795 |
2.83 CI 1.59 / 4.82 SE 0.728 |
DSU |
3.23 CI 1.99 / 5.12 SE 0.713 |
2.59 CI 1.53 / 4.23 SE 0.614 |
2.19 CI 1.22 / 3.74 SE 0.568 |
DSU |
Black or African American only, not Hispanic or Latino |
DNA |
6.37 CI 6.14 / 6.61 SE 0.120 |
5.53 CI 5.32 / 5.75 SE 0.110 |
5.72 CI 5.50 / 5.94 SE 0.112 |
5.01 CI 4.81 / 5.22 SE 0.104 |
4.68 CI 4.48 / 4.88 SE 0.100 |
3.91 CI 3.74 / 4.09 SE 0.090 |
3.58 CI 3.41 / 3.75 SE 0.086 |
White only, not Hispanic or Latino |
DNA |
3.36 CI 3.29 / 3.43 SE 0.036 |
3.08 CI 3.01 / 3.15 SE 0.034 |
3.18 CI 3.12 / 3.25 SE 0.035 |
2.98 CI 2.91 / 3.04 SE 0.034 |
2.74 CI 2.68 / 2.80 SE 0.032 |
2.40 CI 2.34 / 2.46 SE 0.030 |
2.22 CI 2.16 / 2.27 SE 0.029 |
2 or more races, not Hispanic or Latino |
DNA |
2.97 CI 2.46 / 3.56 SE 0.269 |
2.79 CI 2.30 / 3.37 SE 0.262 |
2.54 CI 2.09 / 3.08 SE 0.242 |
2.81 CI 2.35 / 3.36 SE 0.246 |
2.56 CI 2.12 / 3.08 SE 0.236 |
1.92 CI 1.54 / 2.37 SE 0.202 |
1.64 CI 1.30 / 2.05 SE 0.184 |
Deaths with hepatitis C as the underlying or contributing cause by Age group, 2017-2024 †
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
<18 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
0-4 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
5-11 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
12-17 years |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
18-44 years |
0.59 CI 0.54 / 0.63 SE 0.022 |
0.61 CI 0.56 / 0.65 SE 0.023 |
0.54 CI 0.50 / 0.59 SE 0.022 |
0.65 CI 0.61 / 0.70 SE 0.024 |
0.64 CI 0.60 / 0.69 SE 0.023 |
0.58 CI 0.53 / 0.62 SE 0.022 |
0.50 CI 0.46 / 0.54 SE 0.020 |
0.41 CI 0.37 / 0.45 SE 0.018 |
18-24 years |
0.06 CI 0.03 / 0.09 SE 0.013 |
0.04 CI 0.02 / 0.06 SE 0.011 |
DSU |
0.05 CI 0.03 / 0.09 SE 0.013 |
0.05 CI 0.03 / 0.08 SE 0.012 |
DSU |
DSU |
DSU |
25-44 years |
0.78 CI 0.72 / 0.83 SE 0.030 |
0.80 CI 0.75 / 0.87 SE 0.030 |
0.72 CI 0.67 / 0.78 SE 0.029 |
0.86 CI 0.80 / 0.92 SE 0.031 |
0.85 CI 0.79 / 0.91 SE 0.031 |
0.78 CI 0.72 / 0.84 SE 0.030 |
0.66 CI 0.61 / 0.71 SE 0.027 |
0.54 CI 0.50 / 0.59 SE 0.024 |
45-64 years |
12.84 CI 12.60 / 13.08 SE 0.123 |
11.13 CI 10.90 / 11.36 SE 0.115 |
9.58 CI 9.37 / 9.79 SE 0.107 |
9.19 CI 8.99 / 9.40 SE 0.105 |
8.13 CI 7.93 / 8.32 SE 0.099 |
6.87 CI 6.69 / 7.05 SE 0.091 |
5.64 CI 5.48 / 5.81 SE 0.083 |
4.78 CI 4.63 / 4.93 SE 0.076 |
45-54 years |
6.03 CI 5.80 / 6.27 SE 0.119 |
4.90 CI 4.69 / 5.12 SE 0.108 |
4.10 CI 3.91 / 4.30 SE 0.100 |
3.85 CI 3.66 / 4.05 SE 0.098 |
3.55 CI 3.37 / 3.73 SE 0.093 |
2.75 CI 2.59 / 2.91 SE 0.082 |
2.29 CI 2.15 / 2.45 SE 0.075 |
2.12 CI 1.98 / 2.26 SE 0.072 |
55-64 years |
19.70 CI 19.28 / 20.13 SE 0.217 |
17.26 CI 16.87 / 17.66 SE 0.202 |
14.85 CI 14.49 / 15.22 SE 0.187 |
14.27 CI 13.92 / 14.64 SE 0.183 |
12.48 CI 12.15 / 12.82 SE 0.171 |
10.84 CI 10.52 / 11.15 SE 0.160 |
8.88 CI 8.60 / 9.17 SE 0.146 |
7.39 CI 7.13 / 7.66 SE 0.133 |
65 years and over |
11.26 CI 10.97 / 11.55 SE 0.149 |
10.80 CI 10.52 / 11.09 SE 0.144 |
10.39 CI 10.12 / 10.66 SE 0.139 |
11.64 CI 11.36 / 11.93 SE 0.145 |
11.36 CI 11.08 / 11.64 SE 0.143 |
10.97 CI 10.70 / 11.24 SE 0.138 |
10.03 CI 9.78 / 10.29 SE 0.130 |
9.54 CI 9.30 / 9.79 SE 0.125 |
65-74 years |
14.81 CI 14.38 / 15.25 SE 0.223 |
14.52 CI 14.10 / 14.96 SE 0.218 |
14.29 CI 13.88 / 14.71 SE 0.213 |
15.96 CI 15.53 / 16.40 SE 0.221 |
15.18 CI 14.77 / 15.61 SE 0.212 |
14.96 CI 14.55 / 15.38 SE 0.210 |
13.51 CI 13.13 / 13.91 SE 0.197 |
12.68 CI 12.31 / 13.06 SE 0.189 |
75-84 years |
6.38 CI 5.98 / 6.79 SE 0.208 |
5.92 CI 5.54 / 6.31 SE 0.196 |
5.17 CI 4.82 / 5.53 SE 0.180 |
5.80 CI 5.44 / 6.19 SE 0.188 |
5.79 CI 5.43 / 6.18 SE 0.189 |
5.81 CI 5.46 / 6.18 SE 0.182 |
5.43 CI 5.10 / 5.78 SE 0.172 |
5.84 CI 5.51 / 6.20 SE 0.174 |
85 years and over |
6.03 CI 5.43 / 6.63 SE 0.305 |
4.95 CI 4.43 / 5.52 SE 0.275 |
4.42 CI 3.93 / 4.96 SE 0.259 |
4.97 CI 4.45 / 5.54 SE 0.273 |
4.87 CI 4.33 / 5.46 SE 0.285 |
4.15 CI 3.67 / 4.67 SE 0.253 |
4.18 CI 3.69 / 4.72 SE 0.260 |
3.33 CI 2.89 / 3.80 SE 0.227 |
Deaths with hepatitis C as the underlying or contributing cause by Educational attainment (25-64 years), 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Educational attainment (25-64 years) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis C as the underlying or contributing cause by Family income, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Family income |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis C as the underlying or contributing cause by Health insurance status, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Health insurance status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis C as the underlying or contributing cause by Geographic location, 2017-2024 * 2
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Metropolitan |
4.12 CI 4.05 / 4.19 SE 0.035 |
3.70 CI 3.64 / 3.76 SE 0.033 |
3.26 CI 3.20 / 3.32 SE 0.031 |
3.36 CI 3.30 / 3.43 SE 0.031 |
3.08 CI 3.03 / 3.14 SE 0.029 |
DNA |
DNA |
DNA |
Non-metropolitan |
4.44 CI 4.27 / 4.61 SE 0.089 |
4.06 CI 3.90 / 4.24 SE 0.085 |
3.83 CI 3.67 / 3.99 SE 0.082 |
3.94 CI 3.78 / 4.11 SE 0.083 |
3.75 CI 3.59 / 3.92 SE 0.082 |
DNA |
DNA |
DNA |
Deaths with hepatitis C as the underlying or contributing cause by Marital status (25 years and over), 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Marital status (25 years and over) |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis C as the underlying or contributing cause by Country of birth, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Country of birth |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
DNA |
Deaths with hepatitis C as the underlying or contributing cause by Veteran status, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Veteran status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis C as the underlying or contributing cause by Disability status, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Disability status |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis C as the underlying or contributing cause by Sexual orientation, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Sexual orientation |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
Deaths with hepatitis C as the underlying or contributing cause by Gender identity, 2017-2024 *
(deaths with hepatitis C as the underlying or contributing cause per 100,000 population)
Decrease desired
| Population | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
Gender identity |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |
DNC |